1. Prostate cancer: Are we under the lee?

   • K. H. Kurth

   Editorial Pages: S51 - S52

2. Screening for prostate cancer

   • W. J. Kirkels
   • J. B. W. Rietbergen

   Original Paper Pages: S53 - S56

3. Neo-adjuvant hormonal therapy of prostate cancer

   • U. W. Tann

   Original Paper Pages: S57 - S62

4. Intermittent androgen deprivation in advanced prostate cancer

   • T. M. de Reijke

   Original Paper Pages: S63 - S66

5. The antiandrogen withdrawal syndrome

   • M. P. Wirth
   • S. E. Froschermaier

   Original Paper Pages: S67 - S71

6. Second-line treatment of metastatic prostatic carcinoma

   • D. W. W. Newling

   Original Paper Pages: S73 - S78

7. Quality of life in patients with prostatic carcinoma: A review and results of a study in N⁺ disease Prostate-specific antigen as predictor of quality of life

   • G. van Andel
   • K. H. Kurth
   • J. C. J. M. de Haes

   Original Paper Pages: S79 - S88

8. Role of proteoglycans in cell adhesion of prostate cancer cells: From review to experiment

   • D. H. J. Schamhart
   • K. -H. Kurth

   Original Paper Pages: S89 - S96

9. Stromal inhibition of epithelial cell growth in the prostate; overview of an experimental study

   • A. Kooistra
   • J. C. Romijn
   • F. H. Schröder

   Original Paper Pages: S97 - S105

10. Conservative non-instrumental treatment of benign prostatic hyperplasia

    • J. L. H. Ruud Bosch

    Original Paper Pages: S107 - S114